TXNDC12 and pancreatic adenocarcinoma: To further elucidate the role of TXNDC12 in PAAD, we knocked down TXNDC12 in MIA PaCa-2 and PANC-1 cell lines and verified the knockdown efficiency by Western blot and RT-qPCR (Fig. 1F, G).